News

Gameto Announces Patient Experience Data Demonstrating Investigational In Vitro Maturation Solution Well Tolerated with Higher Patient Satisfaction Rates than Conventional Fertility Stimulation

Read article

Related Articles

News

Gameto Raises $33 Million in Series B Financing to Advance Development and Commercialization of Novel Fertility Treatments

News

Is it Time to Cancel Menopause?

News

Gameto CEO Dr. Dina Radenkovic Recognized Among the Most Exceptional Entrepreneurs at the Goldman Sachs 2023 Builders and Innovators Summit